Zusammenfassung
Die Körpergewebe benötigen für die Aufrechterhaltung der vitalen Funktionen ein Transportsystem, welches die Versorgung mit essentiellen Substraten (z.B. Sauerstoff, Glukose) ebenso wie den Abtransport von „Endprodukten“ (z.B. CO2, NH3) regelt. Da die meisten Gewebe ständig wechselnden Belastungen ausgesetzt sind, müssen anatomische und funktionelle Gegebenheiten des Transportsystems eine große Adaptationsbreite ermöglichen. Dabei ist das Blut als flüssiges Transportmittel anzusehen, dessen korpuskuläre Anteile beim Menschen ein besonders spezialisiertes System darstellen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aasen AO, Dale J, Ohlsson K, Gallimore M (1978) Effects of slow intravenous administration of endotoxin on blood cells and coagulation in dogs. Eur Surg Res 10:194–205
Alestik K, Norrby R (1979) Fatal pneumococcal septicaemia in a young asplenic man. Acta Chir Scand 145:273–275
Allington MJ (1971) Detection of (fibrin)ogen degradation products by a latex clumping method. Scand J Haematol [Suppl] 13:115–119
Ally AI, Horrobin DF (1980) Thromboxane A2 in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension. Prostaglandins and Med 4:431–438
Altura BM (1980) Reticuloendothelial cells and host defense. Acta Microcirc 9:252–294
Ashford TP, Freiman DG (1968) Platelet aggregation at sites of minimal endothelial injury: An electron microskopy study. Am J Pathol 53:599–607
Avikainen V (1977) Coagulation disorders in severely and critically injured patients. Ann Chir Gynaecol 66:269–277
Awbrey BJ, Owen WG, Fry GL, Cheng FH, Hoak JG (1975) Binding of human thrombin to human endothelial cells and platelets. Blood 46:1046
Bachofen M, Weibel ER (1974) Basic pattern of tissue repair in human lungs following unspecific injury. Chest 65:14–19
Baenzinger NL, Dillender MJ, Majerus PW (1977) Cultured human skin fibroblasts and arterial cell produce a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun 78:294–301
Bagge L, Björk I, Saldeen T, Wallin R (1978) Purification of a fibrinolysis inhibitor in serum from posttraumatic patients. Thromb Haemostas 39:97–108
Balis JU, Rappaport ES, Gerber L, Fareed J, Budding F, Messmore L (1978) A primate model for prolonged endotoxin shock. Blood-vascular reactions and effects of gluco-corticoid treatment. Lab Invest 38:511–523
Bayley MB, Clements JA, Osbahr AJ (1967) Pulmonary and circulatory effects of fibrino-peptides. Circ Res 21:469–485
Belew M, Gerdin B, Porath J, Saldeen T (1978) Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin. Thromb Res 13:983–994
Beller FK, Graeff H, Gorstein F (1969) Disseminated intravascular coagulation during the continuous infusion of endotoxin in rabbits. Am J Obstet Gynecol 103:544–554
Beller-Todd B, Archer LT, Hinshaw LB (1979) Recovery from endotoxin shock after extracorporal perfusion without anticoagulation. Circulatory Shock 6:261–269
Bergentz SE, Nilsson IM (1961) Effect of trauma on coagulation and fibrinolysis in dogs. Acta Chir Scand 122:21–29
Bergstein JM (1976) Platelet inhibition of renal cortical fibrinolytic activity in the rabbit. Lab Invest 35:171–178
Bick RL, Bick MD, Fekete LF (1980) Antithrombin III-patterns in disseminated intravascular coagulation. Am J Clin Pathol 73:577–583
Bills TK, Smith JB, Silver MJ (1978) Intracellular regulation of the metabolism of arachi-donic acid in human platelets. Thromb Haemostas 40:219–223
Bohn E, Müller-Berghaus G (1976) The effect of leukocyte and platelet transfusion on the activation of intravascular coagulation by endotoxin in granulocytopenic and thrombocytopenic rabbits. Am J Pathol 84:239–258
Bonnar J (1972) Bacteriemic shock in pregnancy. In: Ledingham I McA (ed) Conference on Shock. Kimpton, London, pp 178–187
Bourgain RH (1978) Inhibition of PGI2 (Prostacyclin) synthesis in the arterial wall enhances the formation of white platelet thrombi in vivo. Haemostasis 7:252–255
Braasch D (1967) Deformierung und Zerstörung von Erythrozyten durch Noradrenalin in normalen und hämorrhagischen Hunden. Pflügers Arch Ges Physiol 296:143–147
Brain MG, Hourihane DOB (1967) Microangiopathic haemolytic anaemia. The occurence of haemolysis in experimentally produced vascular disease. Br J Haematol 13:135–142
Braunstein KM, Dodds EA, Stewart G, Shull KC, Eurenius K (1978) Heparin cofactor activity following thermal injury. Am J Clin Pathol 70:632–636
Breddin K, Báuke J (1965) Thrombozytenagglutination und Gefäßkrankheiten. Blut 11:144–164
Brown DL (1975) Complement und coagulation. Br J Haematol 30:377–382
Büsing CM, Bleyl U (1977) Plasminogen activator activity of pulmonary vessels in shock. Thromb Res 11:285–295
Busch C, Saldeen T, Thorén L (1975) Effect of cavoportal shunt on pulmonary fibrin deposition after intraaortal infusion of thrombin in dog. Acta Chir Scand 141:455–460
Cazenave JP, Dejana E, Kinlough-Rathbone R, Packham MA, Mustard JF (1979) Platelet interactions with the endothelium and the subendothelium : the role of thrombin and prostacyclin. Haemostasis 8:183–192
Chien S (1967) Role of the sympathetic nervous system in hemorrhage. Phys Rev 47:214–218
Chien S (1969) Blood rheology and its relation to flow resistance and transcapillary exchange, with special reference to shock. Adv Microl 2:89–103
Chien S, Usami S, Dellenback RJ, Gregorsen MI (1970) Sheardependent interaction of plasma protein with erythrocytes in blood rheology. Am J Physiol 219:143–153
Chignard M, LeCouedic JP, Vargaftig BB, Benveniste J (1980) Platelet-activating factor (PAF-Acether) secretion from platelets : effect of aggregating agents. Br J Haematol 46:455–464
Clowes GHA (1974) Pulmonary abnormalities in sepsis. Surg Clin North Am 54:993–1013
Coalson JJ, Hinshaw LB, Guenther CA, Berell EL, Greenfield LJ (1975) Pathophysiologic responses of the subhuman primate in experimental septic shock. Lab Invest 32:561–569
Collen D (1976) Identification and some properties of a new fast reacting plasmin inhibitor in human plasma. Eur J Biochem 69:209–216
Colman RW, Robboy SJ, Minna JD (1972) Disseminated intravascular coagulation (DIC) : An approach. Am J Med 52:679–689
Corrigan JJ, Jordan CM (1970) Heparin therapy in septicemia with disseminated intravascular coagulation. Effect on mortality and on corretion of hemostatic defects. N EnglJ Med 283:778–782
Corrigan JJ, Ray WL, May N (1968) Changes in the blood coagulation system associated with septicemia. N Engl J Med 279:851–855
Craddock PR, Hammerschmidt DE, White JG, Dalmasso AP, Jacob HS (1977) Complement (C5a) induced granulocyte aggregation in vitro : a possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 60:261–264
Dale J, Ohlsson K, Nordstoga K, Aasen AO (1980) Intravascular hemolysis and ultra-structural changes of erythrocytes in lethal canine endotoxin shock. Eur Surg Res 12:39–51
Danon D, Skutelsky E (1976) Endothelial surface charge and its possible relationship to thrombogenesis. Ann NY Acad Sci 275:47–63
Davie EW, Fujikawa K (1975) Basic mechanism in blood coagulation. Ann Rev Biochem 44:799–829
Demling RH, Smith M, Günther R, Flynn JT, Gee MH (1981) Pulmonary injury and prostaglandin production during endotoxemia in conscious sheept. Am J Physiol 240:348–353
Deutsch E, Thaler E (1979) Acquired antithrombin III (AT III) deficiency in septicaemia. Thromb Haemostas 42:375
Deykin D (1966) The role of the liver in serum-induced hypercoagulability. J Clin Invest 45:256–263
Diffang C, Lindquist O, Saldeen T (1973) Distribution of intravascular fibrin deposits in various organs in the microembolism syndrome. Forensic Sci 2:53
Donati MB, Misiani R, Marchesi D, Livio M, Mecca G, Remuzzi G, de Gaetano G (1980) Hemolytic-uremic syndrome, prostaglandins and plasma factors. In: Remuzzi G, Mecca G, Gaetano G de (eds) Haemostasis, prostaglandins and renal disease. Raven Press, New York, pp 283–290
Dormandy JA (1980) Haemorrheological aspects of thrombosis. Br J Haematol 45:519–522
Douglas WW (1975) Autacoids. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 589–590
Driessen GK, Heidtmann H, Schmid-Schönbein H (1979) Effect of hematokrit on red cell flow velocity in the capillaries of rat mesentary during hemodilution and hemocon-centration. Pfluegers Arch 380:1–6
Duesberg R, Schröder W (1944) Pathophysiologie und Klinik der Kollapszustände, Hir-zel, Leipzig
Eckhardt TH, Nossel HL, Hurlet-Jensen A, LaGamma KS, Owen J, Auerbach M (1981) Measurement of desarginine fibrinopeptide B in human blood. J Clin Invest 67:809–816
Egeberg O (1965) Inheritde antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrhag 13:516–530
Ehrly AM (1971) Rheologische Probleme beim Schock. Med Welt 22:1167–1168
Ehrly AM (1972) Rheologische Probleme beim Schock. In: Gros D (Hrsg) Kardiogener, baktiotoxischer und Volumen-Mangelschock. Schattauer, Stuttgart, S 67–70
Ehrly AM (1974) Beeinflussung der gestörten Mikrozirkulation durch rheologisch wirksame Pharmaka. In: Ahnefeld FW, Burri G, Dick W, Halmagyi (Hrsg) Klinische Anästhesiologie und Intensivtherapie. 5. Mikrozirkulation. Springer, Berlin Heidelberg New York, S 196
Encke A, Lasch HG, Peterich J, Schmidt HD, Schmier J (1969) Blood coagulation and fibrinolytic therapy in normotensive haemorrhagic shock of the dog. Z Kreislaufforsch 58:1298–1307
Epstein MD, Beller F, Douglas GW (1968) Kidney tissue activator of fibrinolysis in relation to pregnancy. Obstet Gynecol 32:494–504
Esmon CT, Suttie JW, Jackson CM (1975) The functional significance of Vitamin K action. Difference in phospholipid binding between normal and abnormal protrhom-bin. J Biol Chem 250:4095–4099
Eurenius K, Mortensen RF, Meserol PM (1972) Platelet and megakaryocyte kinetics following thermal injury. J Lab Clin Med 79:247–257
Eurenius K, Rossi TD, McEnen DD (1974) Blood coagulaton in burn injury. Proc Soc Exp Biol Med 147:878–882
Fallon YT, Stehbens WE (1972) Venous endothelium of experimental arteriovenous fistulas in rabbits. Circ Res 31:546–556
Findling JW, Pohlmann GP, Rose HD (1980) Fulminant gram-negative bacillemia (DF-2) following a dog bite in an asplenic woman. Am J Med 68:154–156
Fine J (1975) Reflexions. Contempory Surgery 7:48–56
Flenker H (1981) Pathophysiologie und Pathologie der Schocklunge. Klinikarzt 10:658–667
Fletcher AP, Alkjaersig N, O’Brien J, Tulevski VC (1970) Blood hypercoagulability and thrombosis. Trans Assoc Am Physicians 83:159–167
Flynn JT, Appert HE, Howard JM (1975) Arterial prostaglandin Al E1 and F2 concentrations during hemorrhagic shock in dog. Circulatory Shock 2:155–163
Folkow B, Neil E (1971) Circulation. New York University Press, New York
Freid MA, Voski KL (1968) The importance of underlying diseases in patients with gram-negative bacteriemia. Arch Intern Med 121:418–423
Freudenberg N (1978) Endothelium and shock. Pathol Res Pract 162:105–114
Freudenberg N, Riese KH (1976) Characterization of the normal cortic endothelium of adult rats and changes due to endotoxin shock. I. Communication: Light microscopy, autoradiographie, DNA-cytophotometry, and enzyme histochemistry. Beitr Pathol 159:125–142
Fröhlich JG, Qgletree M, Peskar BA, Brigham KL (1980) Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res 7:745–750
Fujikawa K, Coan MH, Legaz ME, Davie EW (1974) The mechanism of activaton of bovine Factor X (Stuart factor) by intrinsic and extrinsic pathways. Biochem 13:5290–5299
Fung YC (1966) Theoretical considerations of the elasticity of red cells and small clood vessels. Fed Proc 25:1761–1762
Gabbiani F, Badonell MC (1975) Early changes of endothelial clefts after thermal injury. Micro vase Res 10:65–75
Gaetano G de (1981) Platelets, prostaglandines and thrombotic disorders. Clin Haematol 10:297–326
Gaynor E (1971) Increased mitotic activity in rabbit endothelium after endotoxin. An autoradiographic study. Lab Invest 24:318–320
Gaynor E, Bouvier C, Spaet Th (1970) Vascular lesions: possible pathogenetic basis of the generalized Shwartzman reaction. Science 170:986–988
Gehrke CF, Penner JA, Neiderhuber J (1971) Coagulation defects in burned patients. Surg Gynecol Obstet 133:613–616
Gerrity RG, Richardson M, Caplan BA, Cade JF, Hirsh J, Schwartz CJ (1976) Endotoxin induced vascular endothelial injury, enface morphology, 3H-thymidine uptake and circulating endothelial cells in dogs. Exp Mol Pathol 24:59–69
Ginsberg MH, Painter RG, Forsyth J, Birdwell C (1980) Thrombin increases expression of fibronectin antigen on the platelet surface. Proc Natl Acad Sci USA 77:1049–1053
Gjesdahl K (1976) Platelet function and plasma free fatty acids during acute myocardial infarction and severe angina pectoris. Scand J Haematol 17:205–212
Godal HC, Abildgaard U (1966) Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 3:342–350
Goldstone J, Schmid-Schönbein H, Wells R (1970) The rheology of red blood cell aggregates. Microvasc Res 2:273–286
Good RA, Thomas L (1953) Studies on the generalized Shwartzman reaction. IV Prevention of the local and generalized Shwartzman reactions with heparin. J Exp Med 97:871–888
Gordon YB, Martin MH, Landon J, Cherd T (1975) The development of radioimmunas-says for fibrinogen fragments D and E. Br J Haematol 29:109–119
Graeff H, Kuhn W, Zander J (1974) Sepsis in der Geburtshilfe. Therapiewoche 24:6173–6174
Graeff H, Kuhn W, Zander J (1975) Endotoxin shock in obstretics. In: Urbaschek R, Neter E (eds) Gram-negative bacterial infections. Springer, Wien, pp 446
Guyton AC, Granger HJ, Taylor AE (1971) Interstitial fluid pressure. Physiol Rev 51:527–530
Haerem JW (1972) Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexspectedly of coronary artery disease. Atherosclerosis 15:199–213
Haerem JW (1974) Mural platelet microthrombi and major acute lesions of main epiear-dial arteries in sudden coronary death. Atherosclerosis 19:529
Hamberg M, Samuelsson B (1973) Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70:899–903
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes : a new group of biologically active compounds derived from prostaglandin endoperoxydes. Proc Natl Acad Sci USA 72:2994–2998
Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS (1980) Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome : pathological relevance and possible prognostic value. Lancet 1:947–949
Hardaway RM (1978) Acute respiratory distress syndrome and disseminated intravascular coagulation. South Med J 71:596–598
Hardaway RM (1979a) Cellular and metabolic effects of shock. J Am Vet Med Assoc 175:81–86
Hardaway RM (1979b) Importance of capillary perfusion. Am J Surg 138:678–679
Hardaway RM (1980) Mechanism of traumatic shock. Surg Gynecol Obstet 151:65–69
Hardaway RM, Brewster WR, Elovitz MJ (1966) The influence of vasoconstriction and acidosis on disseminated intravascular coagulation. Surgery 59:804–811
Hardaway RM, James PM Jr, Andersen RW, Bredenberg CE, West RL (1967) Intensive study and treatment of shock in man. JAMA 199:779–790
Hardaway RM, Dixon RS, Foster EF (1976) The effect of hemorrhagic shock on disseminated intravascular coagulation. Ann Surg 184:43–45
Hardaway RM, Dumke R, Gee T, Meyers T, Joyner J, Graf J, Lee D, Revels J (1979) The danger of hemolysis in shock. Ann Surg 189:373–376
Hardaway RM, Dumke R, Gee T, Meyers T, Joyner J, Graf J, Lee D, Revels J (1980) Influence of fibrinogen levels in dogs on mortality from hemorrhagic and traumatic shock. J Trauma 20:417–419
Harlan JM, Harker LA (1981) Hemostasis, thrombosis and thromboembolic disorders. The role of arachidonic acid metabolites in platelet-vessel wall interactions. Med Clin North Am 65:855–880
Harms D, Pape GR, Bohle A (1973) Pathologische Anatomie des Waterhouse-Fridrich-sen-Syndroms unter besonderer Berücksichtigung der disseminierten intravaskulären Koagulation. Dtsch Med Wochenschr 38:542–547
Hartveit F, Halleraker B (1970) Intravascular changes in kidney and lungs after external cardie massage: A preliminary report. J Pathol 102:54–58
Hatton MWC, Berry CR, Regoezi E (1978) Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta. Thromb Res 13:655–670
Hauck G (1971) Organisation und Funktion der terminalen Strombahn. In: Braueisen E (Hrsg) Physiologie des Kreislaufs, Bd I. Springer, Berlin Heidelberg New York, S 99–144
Hauck G, Schröer H (1975) Instability of the postcapillary blood flow. Bibl Anat 12:169–170
Hawiger J, Niewiarowski S, Gurewich V, Thomas DP (1970) Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med 75:93
Hedner U (1973) Studies on an inhibitor of plasminogen activation in human serum. Thrombos Diathes Haemarrhag 30:414–424
Heene DL (1975) Gerinnungsstörungen bei portaler Hypertension. Z Gastroenterol 13:147–157
Heene DL (1977) Disseminated intravascular coagulation: Evaluation of therapeutic approaches. Semin Thromb Haemostas 3:291–317
Heene DL, Lasch HG (1977) Klinische Aspekte der Mikrozirkulationsstörung unter besonderer Berücksichtigung des Schocks. In: Handbuch der allgemeinen Pathologie, Bd III/7. Springer, Berlin Heidelberg New York, S 889–995
Heene DL, Matthias FR (1978) Hämostasestörungen im Schock. Verh Dtsch Ges Pathol 62:103–111
Heene DL, Lasch HG, Matthias FR (1976) Gerinnungsstörungen und Verbrauchskoagu-lopathie bei polytraumatisierten Patienten. Intensivbehandlung 1:42–48
Heideman M, Kaijser B, Gelin LE (1979) Complement activation early in endotoxin shock. J Surg Res 26:74–78
Heine H (1981) Die initiale Granulozytose der Lunge nach Eintritt eines Schockereignisses. Ursachen und Entwicklung. Med Welt 37:2–12
Heller L, Halberstadt E (1970) Der septische Schock. Gynaekologie 92:111–119
Heller W, Domres B, Hausdörfer J, Veihelmann D (1979) Stoffwechseluntersuchungen im traumatischen Schock unter Berücksichtigung therapeutischer Maßnahmen. Med Welt 30:965–970
Hellinger J, Sturm G, Oltmanns G, Heuse E, Schuh W, Seidel M (1975) Untersuchungen der Blutgerinnung und Thrombozytenfunktion im reversiblen hämorrhagischen Schock. Z Exp Chir 8:185–189
Hinshaw LH, Solomon LA, Erdös EG, Reins DA, Gunter BJ (1967) Effect of acetylsalicy-lic acid on the canine response to endotoxin. J Pharmacol Exp Ther 157:665–671
Hope W, Martin TJ, Chesterman CN, Morgan FJ (1979) Human β-thromboglobulin inhibits PGI2-production and binds to a specific site in bovine aortic endothelial cells. Nature 282:210–212
Jackson CM, Suttie JW (1977) Recent developments in understanding the mechanisms of vitamin K and vitamin K antagonist drug action and the consequences of vitamin K action in blood coagulation. Prog Hematol 10:233–259
Jacob HS (1981) The role of activated complement and granulocytes in shock states and myocardial infarction. J Lab Clin Invest 38:645–653
Jakschik BA, Marshall GR, Kourik JL, Needleman P (1974) Profile of circulating vasoac-tive substances in hemorrhagic shock and their pharmacological manipulation. J Clin Invest 54:842–852
Jesty J (1978) The inhibition of activated bovine coagulation factors X and VII by antithrombin III. Arch Biochem Biophys 185:165–173
Jøorgensen L (1971) Mechanism of thrombosis. Pathobiol Annu 1:139–204
Kalowski S, Howes EL, Margaretten W, McKay DG (1975) Effects of intravascular clotting on the activation of the complement system. Am J Pathol 78:525–536
Kane MA, May JE, Frank MM (1973) Interactions of the classical and alternate complement pathway with endotoxin lipolysesaccharide. J Clin Invest 52:370–376
Kazmier FJ, Bowie EJW, Hagedorn AB, Owen CA (1974) Treatment of intravascular coagulation and fibrinolysis (ICF) syndromes. Mayo Clin Proc 49:665–672
Kierulf P (1973) Studies of soluble fibrin in plasma. II. N-terminal analysis of a modified fraction I (Cohn) from patient plasmas. Scand J Clin Lab Invest 31:37–42
Kinlough-Rathbone RL, Packham MA, Reimer HJ, Cazenave JP, Mustard JF (1977) Mechanism of platelet shape change, aggregation and release induced by collagen, thrombin or A23, 187. J Lab Clin Med 90:707–719
Kjeldsen K, Thomsen HK (1975) The effect of hypoxia on the fine structure of the aortic intima in rabbits. Lab Invest 33:533–543
Koch HH, Keller O (1973) Unsere Erfahrungen mit den prophylaktischen Maßnahmen zur Verhinderung des Sanarelli-Shwartzman-Phänomens (SSP) beim septischen Abort. Geburtshilfe Frauenheilkd 33:460–463
Kramer W, Müller-Berghaus G (1977) Effect of platelet antiserum on the activation of intravascular coagulation by endotoxin. Thromb Res 10:47–70
Künzer W, Karitzky D, Pringsheim W (1970) Atemnotsyndrom und disseminierte intrava-sale Gerinnung. Dtsch Med Wochenschr 95:2141–2144
Künzer W, Sutor AH, Niederhoff H, Pringsheim W, Karitzky D, Altemeyer KH, Schenk W, Schreiber R (1974) Gerinnungsphysiologische Aspekte und fibrinolytische Therapie des Schocks. Monatsschr Kinderheilkd 122:116–126
Kuhn W, Graeff H (1971a) Gerinnungsstörungen in der Geburtshilfe. Thieme, Stuttgart, S 90–105
Kuhn W, Graeff H (1971b) Infizierter Abort und disseminierte intravasale Gerinnung (DIG). Heparinprophylaxe und Frühdiagnostik der DIG. Med Welt 22:1199–1200
Kunze J, Vogt W (1971) Significance of phospholipase A for prostaglandin formation. Ann NY Acad Sci 180:123–125
Kurien VA, Oliver MF (1966) Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet 2:122–127
Lamy M, Fallat RJ, Koeniger E, Dietrich HP, Ratliff JL, Eberhard RC, Tucker HJ, Hill JD (1976) Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 114:267–284
Lanser K, Wiehert P von (1981) Akutes Lungenversagen — Schocklunge. Internist Welt 6:217–223
Largo R, Heller V, Straub PW (1976) Detection of soluble intermediates of the fibrino-gen-fibrin-conversion using erythrocytes coated with fibrin nomomers. Blood 47:991–1002
Lasch HG (1959) Untersuchungen zur Dynamik im System der Blutgerinnungsfaktoren („latente Gerinnung“ in der Blutbahn). Habilitationsschrift, Heidelberg
Lasch HG (1975) Verbrauchskoagulopathie — Ursache oder Folge von Blutungen. Med Welt 26:697–703
Lasch HG (1976) Akute Atmungsinsuffizienz — Schocklunge. Therapiewoche 26:8767–8774
Lasch HG (1978) Klinik und Pathophysiologie des Schocks. Verh Dtsch Ges Pathol 62:2–10
Lasch HG, Heene DL (1974) Heparin therapy of diffuse intravascular coagulation (DIC). Thrombos Diathes Haemorrhag 33:105–106
Lasch HG, Müller-Berghaus G (1980) Pro-Kontra: Verbrauchskoagulopathie — Heparin-behandlung? Argumente für eine Heparinbehandlung. Internist 21:382–384
Lasch HG, Róka L (1954) Über den Bildungsmechanismus der Gerinnungsfaktoren Prothrombin und Faktor VII. Klin Wochenschr 32:460–464
Lasch HG, Rodriguez-Erdmann F, Krecke HJ (1960) Quantitative und qualitative Veränderungen der Thrombozyten beim Sanrelli-Shwartzman-Phänomen. Verh Dtsch Ges Inn Med 66:992–998
Lasch HG, Mechelke K, Nusser E, Daoud F (1961a) Der Einfluß der Fibrinolyse auf den Verlauf des hämorrhagischen Schocks. Klin Wochenschr 39:1137–1141
Lasch HG, Rodriguez-Erdmann F, Schimpf K (1961b) Antithrombin III und Anti-Blutthrombokinase bei experimenteller Verbrauchskoagulopathie (am Beispiel des Sanarelli-Shwartzman-Phänomens). Klin Wochenschr 39:645–647
Lasch HG, Rodriguez-Erdmann F, Westenhöfer D (1961c) Der Einfluß der Fibrinolyse auf den Verlauf des Sanarelli-Shwartzman-Phänomens. Proc 8th Congress Europ Soc Haematol, Wien. Karger, Basel, S 469
Lasch HG, Mechelke K, Nusser E, Sessner HH (1963) Fibrinolysetherapie im Schock. Experimentelle und klinische Ergebnisse. Thrombos Diathes Haemorrhag [Suppl 3] VII:237–242
Lasch HG, Heene DL, Huth K, Sandritter W (1967) Pathophysiology, clinical manifestations and therapy of consumption coagulopathy („Verbrauchskoagulopathie“). Am J Cardiol 20:381–391
Lasch HG, Huth K, Heene DL, Müller-Berghaus G, Hörder MH, Janzarik H, Mittermayer C, Sandritter W (1971) Die Klinik der Verbrauchskoagulopathie. Dtsch Med Wochenschr 96:715–728
Lerner RG, Goldstein R, Cummings G (1971) Stimulation of human leukocyte thrombo-plastic activity by endotoxin. Proc Soc Exp Biol Med 138:145–148
Lewis DH, Meilander S (1962) Competitive effects of sympathetic control and tissue metabolites on resistance and capacitance vessels and capillary filtration in skeletal muscle. Acta Physiol Scand 56:162
Lewy RJ, Smith JB, Silver MJ, Saia J, Walinsky P, Wiener L (1979) Detection of thrombo-xane B2 in peripheral blood of patients with Prinzmeta’s angina. Prostaglandines and Medicine 5:243–248
Lipinski B, Worowski K (1968) Detection of soluble fibrin monomer complexes in blood by means of protamine sulfate test. Thrombos Diathes Haemorrhag 20:44
Lollar P, Owen WG (1980) Clearance of thrombin from the circulation by high-affinity binding sites on endothelium: possible role in the interactivation of thrombin by antithrombin III. Circulation [Suppl III] 62:278
Loskutoff DJ (1979) Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells. J Clin Invest 64:329–332
Loskutoff DJ, Edgington TS (1977) Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci (USA) 74:3903–3907
Lowe GDO, Forbes CD (1981) Blood rheology and thrombosis. Clin Haematol 10:343–367
Lowe GDO, Barbenel JG, Forbes CD (eds) (1981) Clinical aspects of blood viscosity and cell deformability, Springer, Berlin Heidelberg New York
Maca RD, Hoak JC (1974) Endothelial injury and platelet aggregation associated with acute lipid mobilization. Lab Invest 30:589–595
Mammen EF (1981) Die Physiologie der Hämostase und ihre pharmakologische Beeinflussung: In: Gross R, Holtmeier HJ (Hrsg) Blutgerinnung und Fibrinolyse. Thieme, Stuttgart New York, S 21–33
Marcus AJ (1979) The role of prostaglandins in platelet function. Prog Hematol 11:147–171
Margaretten W, Zunker HO, McKay DG (1964) Production of the generalized Shwartz-man reaction in pregnant rats by intravenous infusion of thrombin. Lab Invest 13:552–559
Mason RG, Sharp D, Chuang H, Mohammad S (1977) The endothelium. Arch Pathol Lab Med 101:61–64
Matthias FR (1978) Soluble plasma fibrin and platelet prostaglandin endoperoxides following myocardial infarction. Haemostasis 7:273–281
Matthias FR, Lasch HG (1982) Disseminierte intravaskuläre Gerinnung und Kreislaufschock. Hämostaseologie 2:60–67
Matthias FR, Reinicke R, Heene DL (1977) Affinity chromatography and quantitation of soluble fibrin from plasma. Thromb Res 10:365–384
Maynard YR, Dreyer BE, Pitlick FA, Nemerson Y (1975) Tissue factor activity of endothelial and other cultured human cells. Blood 46:1046
McKay DG (1963) A partial synthesis of the generalized Shwartzman reaction. Fed Proc 22:1373–1379
McKay DG (1964) Disseminated intravascular coagulation. An intermediary mechanism of disease. Hoeber, Harper & Row, New York
McKay DG (1973) Vessel wall and thrombogenesis — Endotoxin. Thrombos Diathes Haemorrhag 29:11–26
McManus WF, Eurenixis K, Bruitt BA (1973) Disseminated intravascular coagulation in burned patients. J Trauma 13:416–422
Mehta B, Briggs DK, Sommers SC, Karpatkin M (1972) Disseminated intravascular coagulation following cardiac arrest: a study of 15 patients. Am J Med Sci 264:353–363
Mellander S, Lewis DH (1963) Effect of hemorhagic shock on the reactivity of resistance and capacitance vessels and on capillary filtration transfer in cat skeletal muscle. Circulation Res 13:105–118
Mersky C, Kleiner GJ, Johnson AJ (1966) Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28:1
Messmer K, Brendel W (1971) Pathophysiologische Aspekte des hypovolämischen kardio-genen und bakteriotoxischen Schocks. Med Welt 22:1159–1164
Miller H, Oaks W (1979) Therapy for septic shock. Compr Ther 5:26–32
Miller RD, Robbins TO, Tang MJ, Barton SL (1971) Coagulation defects associated with massive blood transfusion. Ann Surg 174:794–801
Minna JD, Robboy SJ, Colman RW (1974) Disseminated intravascular coagulation in man. Thomas, Springfield
Mittermayer C (1975) Pathology of shock. Med Welt 26:1473–1474
Mittermayer C, Madreiter M, Schindera F, Hugh K (1971) Über Endokarditis verrueosas simplex bei Schock und Verbrauchskoagulopathie. Verh Dtsch Ges Pathol 55:350–353
Mittermayer C, Riede Un, Bleyl U, Herzog H, Wiehert P von, Riesner K (1978) Schocklunge. Verh Dtsch Ges Pathol 62:11–65
Moncada S (1980) Prostacyclin and thromboxane A2 in the regulation of platelet-vascular interactions. In: Reunuzzi G, Mecca G, Gaetano G de (eds) Hemostasis, prostagland-ins and renal disease. Raven, New York, pp 175–184
Moncada S, Vane JR (1978) Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 34:129–135
Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Moncada S, Herman AG, Higgs EA, Vane JR (1977) Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thromb Res 11:323–344
Moriau M, Rodhain J, Noel H (1974) Comparative effects of proteinase inhibitors, plas-minogen antiactivatprs, heparin and acetylsalicylic acids on the experimental disseminated intravascular coagulation induced by thrombin. Thrombos Diathes Haemorrhag 32:171–188
Moroi M, Aoki N (1976) Isolation and characterization of α2-plasmin inhibitor from human plasma. J Biol Chem 251:5956–5965
Morrison DC, Cochrane CG (1974) Direct evidence for Hageman factor (Factor XII) activation by bacterial lipopolysaccharides (endotoxin). J Exp Med 140:797–811
Morrison DG, Kline LF (1977) Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides. J Immunol 118:362–368
Müller-Berghaus G (1977) Pathogenese der Blutgerinnungsstörungen bei Sepsis. In: Marx R, Thies HA (Hrsg) Infektionen, Blutgerinnung und Hämostase. Schattauer, Stuttgart, S 215–220
Müller-Berghaus G, Eckhardt T (1975) The role of granulocytes in the activation of intravascular coagulation and the precipitation of soluble fibrin by endotoxin. Blood 45:631–641
Müller-Berghaus G, Lasch HG (1975) Microcirculatory disturbances induced by generalized intravascular coagulation. In: Born GVR, Eichler O, Farah A, Herken H, Welch AD (eds) Handbook of experimental pharmacology, vol XVI/3. Springer, Berlin Heidelberg New York, pp 429–513
Müller-Berghaus G, Lohmann F (1974) The role of complement in endotoxin-induced disseminated intravascular coagulation. Studies in congenitally C6-deficient rabbits. Br J Haematol 28:403–418
Müller-Berghaus G, Schneeberger R (1971) Hageman factor activation in the generalized Shwartzman reaction induced by endotoxin. Br J Haematol 21:513–527
Müller-Berghaus G, Bohn E, Höbel W (1976) Activation of intravascular coagulation by endotoxin: the significance of granulocytes and platelets. Br J Haematol 33:213–220
Mustard JF, Kinlough-Rathbone RL, Packham MA (1980) Prostaglandins and platelets. Ann Rev Med 31:89–96
Neef H, Richter M, Fischer U (1974) Veränderungen des Blut pH und Gerinnungspotential. Anaesthesist 23:158–161
Neuhof H (1975) Changes in hemodynamics and gas metabolism after endotoxin injecton. In: Urbaschek B, Urbaschek R, Neter E (eds) Gram-negative bacterial infections. Springer, Wien New York, pp 256–264
Neuhof H (1979) Kreislaufmsuffizienz, Schock. In: Vossschulte K, Lasch HG, Heinrich F (Hrsg) Innere Medizin und Chirurgie. Ein integriertes Lehrbuch unter Berücksichtigung des Gegenstandskatalogs. Thieme, Stuttgart, S 154–171
Neuhof H, Wolf H (1976) Die Sauerstoffaufnahme des Organismus in Abhängigkeit von der Kreislauffunktion. In: Zinderl M, Purschke R (Hrsg) Neue kontinuierliche Methoden zur Überwachung der Herz-Kreislauffunktion. Thieme, Stuttgart
Neuhof H, Hey D, Glaser E, Wolf H, Lasch HG (1975) Hemodynamic reactions induced gy streptokinase therapy in patients with acute myocardial infarction. Eur J Intensive Care Med 1:27–30
Neuhof H, Mittermayer C, Freudenberg N (1978) Makro- und Mikrozirkulation im Schock. Verh Dtsch Ges Pathol 62:80–102
Niemetz J (1972) Coagulant activity of leukocytes tissue factor activity. J Clin Invest 51:307–313
Nobis H, Bruneder H, Falkensammer C, Fischer M, Gauss P, Korp W, Ogris E, Pracher H, Weißmann A, Wuketich S (1975) Untersuchungen der Blutgerinnung im Coma diabeticum. Intensivmedizin 12:52–60
Nossel H, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler VP (1971) Radioim-munassay of human fibrinopeptide A. Proc Natl Acad Sci USA 68:2350
Nossel HL, Yudelmann J, Canfield RE, Butler VP, Spanondis K, Wilner GD, Qureshi GD (1974) Measurement of fibrinopeptide A in human blood. J Clin Invest 54:43
Nossel HL, Wasser J, Kaplan KL, Gamma KS, Yudelmann J, Canfield RE (1979) Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest 64:1371–1378
Oehler G, Eckhardt T (1981) Labordiagnostische Möglichkeiten bei Verbrauchskoagulo-pathie. Lab Med 5:204–210
Oehler G, Matthias FR (1979) Affinitätschromatographische Fibrinmonomerbestimmung bei chronischen Leberkranken. Verh Dtsch Ges Inn Med 85:481
Oehler G, Wolf H, Schmahl FW, Róka L (1974) Veränderungen der Lipoproteinlipase nach experimenteller Femurfraktur. Res Exp Med 163:31–38
Oehler G, Reinhold L, Trüschler A, Schöndorf T (1982) Antithrombin HI-Verminderung unter katabolen Bedingungen. Vortrag, 2. Kongr Thrombose und Blutgerinnung, Münster, 25.-27.2.82
Orskov F (1978) Virulence factors of the bacterial cell surface. J Infect Dis 137:630
Pareti FI, Manucci PM, D’Angelo A, Smith JB, Santebin L, Galli G (1980) Congenital deficiency of thromboxane and prostacyclin. Lancet 1:898–900
Pepper DS (1979) Macromolecules released from platelet storage organelles. Thromb Haemostas 42:1667–1672
Plow EF, Edgington TS (1977) Localization and characterization of the cleavage-associated neoantigen in the E-domain of fibrinogen. Thromb Haemostas 38:27
Popov-Cenić S, Dohmen M, Baymann E (1972) Reaktive Fibrinolyse unter Heparinbe-handlung im hämorrhagisch-traumatischen und septischen Schock. Med Welt 23:221–224
Prez RM Des, Horowitz HJ, Hook EW (1961) Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro. J Exp Med 114:857–873
Ramadori G, Hopf U (1979) Die klinische Bedeutung von Endotoxin. Inn Med 6:99–108
Rand JH, Sussmann JJ, Gordan RE, v. Chu S, Soloman V (1980) Localization of factor-VIII-related antigen in human vascular subendothelium. Blood 55:752–756
Ratnoff OD (1969) Epsilon amino caproic acid — a dangerous weapon. N Engl J Med 280:1124–1126
Ratnoff OD (1981) The role of haemostatic mechanism. Clin Haematol 10:261–281
Reinicke R, Matthias FR, Lasch HG (1977) Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy. Thromb Res 11:365–375
Riede UN, Mittermayer C, Rohrbach R, Joh K, Vogel W, Fringes B (1982) Mikrothrom-bosierung der Endstrombahn als Ursache schockbedingter Organkomplikationen (unter besonderer Berücksichtigung der Schocklunge). Hämostaseologie 2:49–59
Rinaldo JE, Rogers RM (1982) Adult respiratory distress syndrome. N Engl J Med 306:900–909
Risberg B (1978) Fibrinolysis and Trauma. Eur Surg Res 10:373–381
Rodriguez-Erdmann F (1964) Studies on the pathogenesis of the generalized Shwartzman reaction. I. Alteration in the coagulation system during the generalized Shwartzman reaction of the pregnant rabbit. Thrombos Diathes Haemorrhag 12:452–461
Rosenberg RD (1975) Actions and interactions of antithrombin and heparin. N Engl J Med 292:146
Rosenblum WJ (1972) Erythrocyte velocity and fluorescein transit time through the cerebral microcirulation in experimental polycythemia. J Neuropathol Exp Neurol 31:126–131
Rosenblum W, El-Sabban F (1978) Enhancement of platelet aggregating by tranylcypro-mine in mouse cerebral microvessels. Circ Res 43:238–241
Rotter W (1971) Das morphologische Substrat des Schocks. Med Welt 22:1175–1180
Ryan SF, Ryan US (1977) Pulmonary endothelials cells. Fed Proc 36:2683–2691
Sakkariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII — von Willebrand-factor bound to subendothelium. Nature 279:636–638
Saldeen T (1970) The importance of intravascular coagulation and inhibition of the fibrinolytic system in experimental fat embolism. J Trauma 10:287–298
Saldeen T (1976) The microembolism syndrome. Microvasc Res 11:227
Saldeen T (1979a) Blood coagulation and shock. Pathol Res Pract 165:221–252
Saldeen T (1979b) The microembolism syndrome: A review. In: Saldeen T (ed) The microembolism syndrome. Almquist & Winsell, Stockholm, pp 7–44
Saldeen T, Busch C, Modig J, Olerud S (1975) The importance of fibrin, platelets and fat droplets in the pulmonary vessel for decrease in PaO2 during a standardized trauma, total hip replacement. Microvasc Res 10:239
Schiffmann S, Rapaport SI, Chong MMY (1973) Platelets and initiation of intrinsic clotting. Br J Haematol 24:633–642
Schildt BE (1976) The present view of RES and shock. Adv Exp Med Biol 73A:375–387
Schlag G, Voigt WH, Schnells G, Glatzl A (1976) Die Ultrastruktur der menschlichen Lunge im Schock. Anaesthesist 25:512–521
Schmid-Schönbein H (1971) Normale Fließeigenschaften des Blutes und deren krankhafte Veränderungen. Schweiz Med Wochenschr 101:1766–1772
Schmid-Schönbein H (1976) Microrheology of erythrocytes blood viscosity, and the distribution of blood flow in the microcirculation. Int Rev Physiol 9:1–62
Schmid-Schönbein H (1981) Interactions of vasomotion and blood rheology in haemodynamics. In: Lowe GDO, Barbanel JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin Heidelberg New York, pp 49–66
Schmid-Schönbein H, Reiger H (1981) Isovolaemic haemodilution. In: Lowe GDO, Barband JC, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Heidelberg New York, pp 221–226
Schmid-Schönbein H, Gallasch G, Gosen J von, Volger E, Klose HJ (1976) Red cell aggregation in blood flow. Klin Wochenschr 54:149–157
Schöndorf TH, Rosenberg M, Beller FK (1971) Endotoxin-induced disseminated intra-vascular coagulation in nonpregnant rats. A new experimental model. Am J Pathol 65:51–58
Schönenberg H (1970) Zur Pathogenese und Therapie der perakuten Meningokokkensep-sis (Waterhouse-Friedrichsen-Syndrom). Monatsschr Kinderheilkd 118:89
Schröder P (1978) Pathophysiologie des Schocks. In: Gersmayer EF, Yasergil EC (Hrsg) Schock und hypo tone Kreislaufstörungen. Thieme, Stuttgart, S 25–100
Schrör K (1982) Bedeutung von Prostaglandinen und anderen Eicosanoiden für das Verhalten der Mikrozirkulation beim Schock. Biochemische, pathophysiologische und pharmakologische Aspekte. Haemostaseologie 2:73–81
Schulz V, Schnabel KM, Schmidt W (1974) Untersuchungen zum pulmonalen Gasaustausch in der akuten Schockphase und nach Übergang in eine Schocklunge. Klin Wochenschr 52:624–630
Schwarz R (1977) Erfahrungen mit der Heparinprophylaxe des septischen Aborts. Zen-tralbl Gynaekol 100:487–489
Scully RE (1956) Fat embolism in korean battle casualities. Its incidence, clinical significance and pathological aspects. Am J Pathol 32:379–403
Seeger W, Wolf H, Stähler G, Neuhof H, Róka L (1981) Zunahme des Strömungswiderstandes und der Gefäßpermeabilität in der pulmonalen Strombahn als Folge des Metabolismus freier Arachidonsäure. Klin Wochenschr 59:459–461
Sefrin P (1979) Stoffwechselveränderungen bei Polytraumatisierten. Fortschr Med 97:1617–1622
Sefrin P, Brunswig D (1978) Gerinnungsveränderungen bei Polytraumatisierten. Infusionstherapie 5:225–228
Sefrin P, Brunswig D, Seybolt A (1977) Untersuchungen zur Dynamik der Blutgerinnungsstörung beim traumatisch-hämorrhagischen Schock. Chirurg 48:227–231
Selye H (1966) Thrombohemorrhagic phenomena. Thomas, Springfield
Serneri GCN, Masotti G, Poggesi L, Galanti G (1980) Release of prostacyclin into the bloodstream in humans after local blood flow changes. Adv Prostaglandin Throm-boxane Res 7:715–719
Shattil SJ, Bennett JS (1980) Platelets and their membranes in hemostasis: physiology and pathophysiology. Ann Intern Med 94:108–118
Sherman AA, Harwig S, Lee J (1975) In vitro formation and in vivo clearance of fibrinogen/fibrin complexes. J Lab Clin Med 86:100–111
Shirahama T, Cohen AS (1972) The role of mucopolysaccharides in vesicle archtecture and endothelial transport. J Cell Biol 52:198–206
Siegel HJ, Greenspan M, DelGuercio LRM (1967) Abnormal vascular tone, defective oxygen transport and myocardial failue in human septic shock. Ann Surg 504:165–172
Slabber CF, Theiss W, Beller FK (1972) The prevention of endotoxin induced glomerular fibrin deposition by pyrimido-pyrimidine compounds. J Med 3:341–348
Smith JB (1980) The prostanoids in haemostasis and thrombosis. Am J Pathol 99:743–804
Smith JJ, Loegering DJ, McDermatt DJ, Bonin ML (1973) The role of lysosomal hydrola-ses in the mechanism of shock. Adv Exp Med Biol 33:535–543
Smith U, Ryan JW (1972) Pulmonary endothelial cells and the metabolism of adenine nucleotides, kinins and angiotensin I. Adv Exp Med Biol 21:267–276
Spaet TH, Homwitz HI, Zucker-Franklin D, Cintron J, Bizensky JJ (1961) Reticuloendo-thelial clearance of blood thromboplastin by rats. Blood 17:196–205
Spath P, Kunz F, Kroesen G, Gabl F, Holzknecht F, Braunssteiner H (1973) Quantitation of C3 and C4 in patients with severe infections or trauma with and without disseminated intravascular coagulation (DIC). J Immunol 111:312
Spink WW, Reddin J, Zack SJ, Peterson M, Starzecki B, Seljeskog E (1966) Correlation of plasma catecholamine levels with hemodynamic changes. J Clin Invest 45:78–85
Steele PP, Weily HS, Davies H, Genton E (1973) Platelet function studies in coronary artery disease. Circulation 48:1194–1200
Stemerman MB (1974) Vascular intimai components: precursors of thrombosis. Prog Haemostas Thromb 2:1–48
Stenflo J, Suttie JW (1977) Vitamin K-dependent formation of gammacarboxyglutamic acid. Annu Rev Biochem 46:157–172
Straub PW (1980) Pro-Kontra: Verbrauchskoagulopathie — Heparinbehandlung. Argumente gegen eine Heparinbehandlung. Internist 21:385–386
String T, Robinsson AJ, Blaisdell FW (1971) Massive trauma: Effect of intravascular coagulation on prognosis. Arch Surg 102:406–411
Sunder-Plassmann L, Messmer K (1972) Die Dynamik der MikroZirkulation im Schock: Hämorheologische und hämodynamische Veränderungen. Z Prakt Anaesth Wiederbel 7:95–106
Surgenor D (1974) Erythrocytes and blood coagulation. Thrombos Diathes Haemorrhag 32:247–259
Swank RL (1962) Adhesiveness of platelet and leukocytes during acute exsanguination. Am J Physiol 202:261–264
Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol X/2:369–390
Thomas DP (1967) Effect of catecholamines on platelet aggregation caused by thrombin. Nature 215:298–299
Thorgeirsson G, Robertson AL (1978) The vascular endothelium — pathobiologic significance. A review. Am J Pathol 93:803–846
Trobisch H, Rick W (1974) Physiologie der Hämostase. Deutsches Aerzteblatt 1617–1620
Vetter NJ, Strange RC, Adam W, Oliver MF (1974) Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1:284–289
Vik-Mo H (1977) Effects of acute myocardial ischaemia on platelet aggregation in the coronary sinus and aorta in dogs. Scand J Haematol 19:68–74
Vogel GE, Gain T (1982) Behandlung mit Antithrombin III: Indikationen und erste Ergebnisse. Diagnostik und Intensivtherapie 7:179–191
Vogt W (1978) Role of phospholipase A2 in prostaglandin formation. Adv Prostaglandin Thromboxane Res 3:89–93
Walsh PN (1972) The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Br J Haematol 22:393–405
Warren BA, Khan S (1975) The scanning electron microscopy of the lysis of fibrin by endothelium. Br J Exp Pathol 56:340–348
Watts DT, Bragg AD (1967) Blood epinephrine levels and automatic reinfusion of blood during hemorrhagic shock in dogs. Proc Soc Exp Biol Med 96:609–612
Weber PC, Siess W, Scherer B (1979) Vaskuläre, thrombozytäre und rénale Prostagland-ine. Biochemie, Funktion, klinische Aspekte. Klin Wochenschr 57:425–444
Webster J, Rees AJ, Lewis PJ, Hensby CW (1980) Prostacyclin deficiency in haemolytic-uraemic syndrome. Br Med J 281:271
Wecksler BB, Ley CW, Jaffe E A (1978) Stimulation of endothelial cell prostacyclin production by thrombin; trypsin, and ionophore A 23187. J Clin Invest 62:923–930
Weiss HJ, Baumgartner HR, Tschopp TB, Turitto VT, Cohen D (1978) Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand Disease. Blood 51:267–279
Wichert P von (1979) Die Schocklunge. Med Klin 74:1–8
Wichert P von, Riesner K (1977) Die sog Schocklunge, ein Krankheitsbild des Lungenpa-renehyms. Langenbecks Arch Chir 344:157
Ygge J (1970) Changes in blood coagulation and fibrinolysis during the postoperative period. Am J Surg 119:225–232
Yudelmann J, Nossel HL, Kaplan KL, Hirsh J (1978) Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. Blood 51:1189–1195
Zweifach BW (1973) Microcirculation. Annu Rev Physiol 35:117–150
Editor information
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Oehler, G., Lasch, H.G. (1984). Gerinnungsstörungen im Schock. In: Bleifeld, W., et al. Schock. Handbuch der inneren Medizin, vol 9 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82076-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-82076-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82077-9
Online ISBN: 978-3-642-82076-2
eBook Packages: Springer Book Archive